This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.-K.
Right arrow Articles by Harris, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.-K.
Right arrow Articles by Harris, R. C.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2001, p. 6322-6331, Vol. 21, No. 18
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.18.6322-6331.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Cytochrome P450 Epoxygenase Metabolism of Arachidonic Acid Inhibits Apoptosis

Jian-Kang Chen,1 Jorge Capdevila,1,2 and Raymond C. Harris1,*

Departments of Medicine1 and Biochemistry,2 Vanderbilt University, Nashville, Tennessee

Received 2 May 2001/Accepted 1 June 2001

The ubiquitous cytochrome P450 hemoproteins play important functional roles in the metabolism and detoxification of foreign chemicals. However, other than established roles in cholesterol catabolism and steroid hormone biosynthesis, their cellular and/or organ physiological functions remain to be fully characterized. Here we show that the cytochrome P450 epoxygenase arachidonic acid metabolite 14,15-epoxyeicosatrienoic acid (14,15-EET) inhibits apoptosis induced by serum withdrawal, H2O2, etoposide, or excess free arachidonic acid (AA), as determined by DNA laddering, Hoechst staining, and fluorescein isothiocyanate-labeled annexin V binding. In the stable transfectants (BM3 cells) expressing a mutant bacterial P450 AA epoxygenase, F87V BM3, which was genetically engineered to metabolize arachidonic acid only to 14,15-EET, AA did not induce apoptosis and protected against agonist-induced apoptosis. Ceramide assays demonstrated increased AA-induced ceramide production within 1 h and elevated ceramide levels for up to 48 h, the longest time tested, in empty-vector-transfected cells (Vector cells) but not in BM3 cells. Inhibition of cytochrome P450 activity by 17-octadecynoic acid restored AA-induced ceramide production in BM3 cells. Exogenous C2-ceramide markedly increased apoptosis in quiescent Vector cells as well as BM3 cells, and apoptosis was prevented by pretreatment of Vector cells with exogenous 14,15-EET and by pretreatment of BM3 cells with AA. The ceramide synthase inhibitor fumonisin B1 did not affect AA-induced ceramide production and apoptosis; in contrast, these effects of AA were blocked by the neutral sphingomyelinase inhibitor scyphostatin. The pan-caspase inhibitor Z-VAD-fmk had no effect on AA-induced ceramide generation but abolished AA-induced apoptosis. The antiapoptotic effects of 14,15-EET were blocked by two mechanistically and structurally distinct phosphatidylinositol-3 (PI-3) kinase inhibitors, wortmannin and LY294002, but not by the specific mitogen-activated protein kinase kinase inhibitor PD98059. Immunoprecipitation followed by an in vitro kinase assay revealed activation of Akt kinase within 10 min after 14,15-EET addition, which was completely abolished by either wortmannin or LY294002 pretreatment. In summary, the present studies demonstrated that 14,15-EET inhibits apoptosis by activation of a PI-3 kinase-Akt signaling pathway. Furthermore, cytochrome P450 epoxygenase promotes cell survival both by production of 14,15-EET and by metabolism of unesterified AA, thereby preventing activation of the neutral sphingomyelinase pathway and proapoptotic ceramide formation.

* Corresponding author. Mailing address: Division of Nephrology, S 3322, MCN, Vanderbilt University School of Medicine, Nashville, TN 37232. Phone: (615) 343-0030. Fax: (615) 343-7156. E-mail: Ray.Harris{at}mcmail.vanderbilt.edu.

Molecular and Cellular Biology, September 2001, p. 6322-6331, Vol. 21, No. 18
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.18.6322-6331.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Chen, Y., Falck, J. R., Tuniki, V. R., Campbell, W. B. (2009). 20-125Iodo-14,15-Epoxyeicosa-5(Z)-enoic Acid: a High-Affinity Radioligand Used to Characterize the Epoxyeicosatrienoic Acid Antagonist Binding Site. J. Pharmacol. Exp. Ther. 331: 1137-1145 [Abstract] [Full Text]  
  • Simpkins, A. N., Rudic, R. D., Schreihofer, D. A., Roy, S., Manhiani, M., Tsai, H.-J., Hammock, B. D., Imig, J. D. (2009). Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection. Am. J. Pathol. 174: 2086-2095 [Abstract] [Full Text]  
  • Zhang, W., Otsuka, T., Sugo, N., Ardeshiri, A., Alhadid, Y. K., Iliff, J. J., DeBarber, A. E., Koop, D. R., Alkayed, N. J. (2008). Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia. Stroke 39: 2073-2078 [Abstract] [Full Text]  
  • Cheranov, S. Y., Karpurapu, M., Wang, D., Zhang, B., Venema, R. C., Rao, G. N. (2008). An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis. Blood 111: 5581-5591 [Abstract] [Full Text]  
  • Webler, A. C., Popp, R., Korff, T., Michaelis, U. R., Urbich, C., Busse, R., Fleming, I. (2008). Cytochrome P450 2C9-Induced Angiogenesis Is Dependent on EphB4. Arterioscler. Thromb. Vasc. Bio. 28: 1123-1129 [Abstract] [Full Text]  
  • Dhanasekaran, A., Gruenloh, S. K., Buonaccorsi, J. N., Zhang, R., Gross, G. J., Falck, J. R., Patel, P. K., Jacobs, E. R., Medhora, M. (2008). Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am. J. Physiol. Heart Circ. Physiol. 294: H724-H735 [Abstract] [Full Text]  
  • Corenblum, M. J., Wise, V. E., Georgi, K., Hammock, B. D., Doris, P. A., Fornage, M. (2008). Altered Soluble Epoxide Hydrolase Gene Expression and Function and Vascular Disease Risk in the Stroke-Prone Spontaneously Hypertensive Rat. Hypertension 51: 567-573 [Abstract] [Full Text]  
  • Yang, S., Lin, L., Chen, J.-X., Lee, C. R., Seubert, J. M., Wang, Y., Wang, H., Chao, Z.-R., Tao, D.-D., Gong, J.-P., Lu, Z.-Y., Wang, D. W., Zeldin, D. C. (2007). Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-{alpha} via MAPK and PI3K/Akt signaling pathways. Am. J. Physiol. Heart Circ. Physiol. 293: H142-H151 [Abstract] [Full Text]  
  • Morin, C., Sirois, M., Echave, V., Gomes, M. M., Rousseau, E. (2007). Epoxyeicosatrienoic Acid Relaxing Effects Involve Ca2+-Activated K+ Channel Activation and CPI-17 Dephosphorylation in Human Bronchi. Am. J. Respir. Cell Mol. Bio. 36: 633-641 [Abstract] [Full Text]  
  • Koerner, I. P., Jacks, R., DeBarber, A. E., Koop, D., Mao, P., Grant, D. F., Alkayed, N. J. (2007). Polymorphisms in the Human Soluble Epoxide Hydrolase Gene EPHX2 Linked to Neuronal Survival after Ischemic Injury. J. Neurosci. 27: 4642-4649 [Abstract] [Full Text]  
  • Spector, A. A., Norris, A. W. (2007). Action of epoxyeicosatrienoic acids on cellular function. Am. J. Physiol. Cell Physiol. 292: C996-C1012 [Abstract] [Full Text]  
  • Dhanasekaran, A., Al-Saghir, R., Lopez, B., Zhu, D., Gutterman, D. D., Jacobs, E. R., Medhora, M. (2006). Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature. Am. J. Physiol. Heart Circ. Physiol. 291: H517-H531 [Abstract] [Full Text]  
  • Zhang, B.-X., Ma, X., Zhang, W., Yeh, C.-K., Lin, A., Luo, J., Sprague, E. A., Swerdlow, R. H., Katz, M. S. (2006). Polyunsaturated fatty acids mobilize intracellular Ca2+ in NT2 human teratocarcinoma cells by causing release of Ca2+ from mitochondria. Am. J. Physiol. Cell Physiol. 290: C1321-C1333 [Abstract] [Full Text]  
  • Dronadula, N., Rizvi, F., Blaskova, E., Li, Q., Rao, G. N. (2006). Involvement of cAMP-response element binding protein-1 in arachidonic acid-induced vascular smooth muscle cell motility. J. Lipid Res. 47: 767-777 [Abstract] [Full Text]  
  • Zhang, B., Cao, H., Rao, G. N. (2006). Fibroblast Growth Factor-2 Is a Downstream Mediator of Phosphatidylinositol 3-Kinase-Akt Signaling in 14,15-Epoxyeicosatrienoic Acid-induced Angiogenesis. J. Biol. Chem. 281: 905-914 [Abstract] [Full Text]  
  • Zhang, B., Cao, H., Rao, G. N. (2005). 15(S)-Hydroxyeicosatetraenoic Acid Induces Angiogenesis via Activation of PI3K-Akt-mTOR-S6K1 Signaling. Cancer Res. 65: 7283-7291 [Abstract] [Full Text]  
  • Jiang, J.-G., Chen, C.-L., Card, J. W., Yang, S., Chen, J.-X., Fu, X.-N., Ning, Y.-G., Xiao, X., Zeldin, D. C., Wang, D. W. (2005). Cytochrome P450 2J2 Promotes the Neoplastic Phenotype of Carcinoma Cells and Is Up-regulated in Human Tumors. Cancer Res. 65: 4707-4715 [Abstract] [Full Text]  
  • Li, F., Malik, K. U. (2005). Angiotensin II-induced Akt activation is mediated by metabolites of arachidonic acid generated by CaMKII-stimulated Ca2+-dependent phospholipase A2. Am. J. Physiol. Heart Circ. Physiol. 288: H2306-H2316 [Abstract] [Full Text]  
  • Dronadula, N., Liu, Z., Wang, C., Cao, H., Rao, G. N. (2005). STAT-3-dependent Cytosolic Phospholipase A2 Expression Is Required for Thrombin-induced Vascular Smooth Muscle Cell Motility. J. Biol. Chem. 280: 3112-3120 [Abstract] [Full Text]  
  • Neeli, I., Liu, Z., Dronadula, N., Ma, Z. A., Rao, G. N. (2004). An Essential Role of the Jak-2/STAT-3/Cytosolic Phospholipase A2 Axis in Platelet-derived Growth Factor BB-induced Vascular Smooth Muscle Cell Motility. J. Biol. Chem. 279: 46122-46128 [Abstract] [Full Text]  
  • Jiang, H., McGiff, J. C., Quilley, J., Sacerdoti, D., Reddy, L. M., Falck, J. R., Zhang, F., Lerea, K. M., Wong, P. Y-K (2004). Identification of 5,6-trans-Epoxyeicosatrienoic Acid in the Phospholipids of Red Blood Cells. J. Biol. Chem. 279: 36412-36418 [Abstract] [Full Text]  
  • Larsson, S. C, Kumlin, M., Ingelman-Sundberg, M., Wolk, A. (2004). Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am. J. Clin. Nutr. 79: 935-945 [Abstract] [Full Text]  
  • Yellaturu, C. R., Rao, G. N. (2003). A Requirement for Calcium-independent Phospholipase A2 in Thrombin-induced Arachidonic Acid Release and Growth in Vascular Smooth Muscle Cells. J. Biol. Chem. 278: 43831-43837 [Abstract] [Full Text]  
  • Ladd, P. A., Du, L., Capdevila, J. H., Mernaugh, R., Keeney, D. S. (2003). Epoxyeicosatrienoic Acids Activate Transglutaminases in Situ and Induce Cornification of Epidermal Keratinocytes. J. Biol. Chem. 278: 35184-35192 [Abstract] [Full Text]  
  • Potente, M., Fisslthaler, B., Busse, R., Fleming, I. (2003). 11,12-Epoxyeicosatrienoic Acid-induced Inhibition of FOXO Factors Promotes Endothelial Proliferation by Down-Regulating p27Kip1. J. Biol. Chem. 278: 29619-29625 [Abstract] [Full Text]  
  • Yellaturu, C. R., Rao, G. N. (2003). Cytosolic Phospholipase A2 Is an Effector of Jak/STAT Signaling and Is Involved in Platelet-derived Growth Factor BB-induced Growth in Vascular Smooth Muscle Cells. J. Biol. Chem. 278: 9986-9992 [Abstract] [Full Text]  
  • Medhora, M., Daniels, J., Mundey, K., Fisslthaler, B., Busse, R., Jacobs, E. R., Harder, D. R. (2003). Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 284: H215-H224 [Abstract] [Full Text]  
  • Zeng, Z.-Z., Yellaturu, C. R., Neeli, I., Rao, G. N. (2002). 5(S)-Hydroxyeicosatetraenoic Acid Stimulates DNA Synthesis in Human Microvascular Endothelial Cells via Activation of Jak/STAT and Phosphatidylinositol 3-Kinase/Akt Signaling, Leading to Induction of Expression of Basic Fibroblast Growth Factor 2. J. Biol. Chem. 277: 41213-41219 [Abstract] [Full Text]  
  • Lovat, P. E., Oliverio, S., Ranalli, M., Corazzari, M., Rodolfo, C., Bernassola, F., Aughton, K., Maccarrone, M., Hewson, Q. D. C., Pearson, A. D. J., Melino, G., Piacentini, M., Redfern, C. P. F. (2002). GADD153 and 12-Lipoxygenase Mediate Fenretinide-induced Apoptosis of Neuroblastoma. Cancer Res. 62: 5158-5167 [Abstract] [Full Text]  
  • Fleming, I. (2002). To Move or Not To Move?: Cytochrome P450 Products and Cell Migration. Circ. Res. 90: 936-938 [Full Text]  
  • Potente, M., Michaelis, U. R., Fisslthaler, B., Busse, R., Fleming, I. (2002). Cytochrome P450 2C9-induced Endothelial Cell Proliferation Involves Induction of Mitogen-activated Protein (MAP) Kinase Phosphatase-1, Inhibition of the c-Jun N-terminal Kinase, and Up-regulation of Cyclin D1. J. Biol. Chem. 277: 15671-15676 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»